Eli Lilly Begins a Phase 3 Clinical Trial for a Potential COVID-19 Treatment

Eli Lilly Begins a Phase 3 Clinical Trial for a Potential COVID-19 Treatment·Motley Fool
In this article:

The company is now running three separate clinical studies of treatment candidates for the novel coronavirus.

Advertisement